Abstract:Inflammation is tightly regulated by nuclear factor-kappa B (NF-kappaB), and if left unchecked excessive NF-kappaB activation for cytokine overproduction can lead to various pathogenic consequences including carcinogenesis. A proinflammatory cytokine, tumor necrosis factor-alpha (TNF-alpha), can be used to explore possible mechanisms whereby unknown functional pathways modulate the NF-kappaB activity for regulating TNF-alpha-induced inflammation. Given the multifunctional nature of 14-3-3 family proteins and the recent finding of their presence in the TNF-alpha/NF-kappaB pathway network, we used a dual-tagging quantitative proteomic method to first profile the TNF-alpha-inducible interacting partners of 14-3-3 epsilon, the least characterized 14-3-3 isomer in the family. For the first time, we found that TNF-alpha stimulation enhances the interactions between 14-3-3 epsilon and some key components in the mitogen-activated protein kinase (MAPK) signal module which is located at the immediate upstream of NF-kappaB, including transforming growth factor-beta activated kinase-1 (TAK1) and its interacting protein, protein phosphatase 2C beta (PPM1B). By using confocal laser scanning, we observed the TNF-alpha-induced colocalizations among 14-3-3 epsilon, TAK1, and protein phosphatase 2C beta (PPM1B), and these interactions were also TNF-alpha-inducible in different cell types. Further, we found that during the full course of the cellular response to TNF-alpha, the interactions between 14-3-3 epsilon and these two proteins were dynamic and were closely correlated with the time course-dependent changes in NF-kappaB activity, suggesting that these 14-3-3 epsilon interactions are the critical points of convergence for TNF-alpha signaling for modulating NF-kappaB activity. We then postulated a mechanistic view describing how 14-3-3 epsilon coordinates its dynamic interactions with TAK1 and PPM1B for differentially modulating TNF-alpha-induced changes in NF-kappaB activity. By using bioinformatics tools, we constructed the network involving most of the 14-3-3 epsilon interacting proteins identified in our proteomic study. We revealed that 14-3-3 epsilon coordinates the cross talks between the MAPK signal module and other molecular pathways/biological processes primarily including protein metabolism and synthesis, DNA repair, and cell cycle regulation where pharmacological targets for therapeutic intervention could be systematically located.

IKKβ Regulates Endothelial Thrombomodulin in a Klf2‐dependent Manner

Dual Regulation of Tumor Necrosis Factor-Α on Myosin Light Chain Phosphorylation in Vascular Smooth Muscle

JNK-ATF-2 Inhibits Thrombomodulin (TM) Expression by Recruiting Histone Deacetylase4 (HDAC4) and Forming a Transcriptional Repression Complex in the TM Promoter.

Mechanism of the Tumor Necrosis Factor Α-Mediated Induction of Endothelial Tissue Factor

IκB Kinase is an Essential Component of the Tpl2 Signaling Pathway

Both Internalization and AIP1 Association Are Required for Tumor Necrosis Factor Receptor 2-Mediated JNK Signaling.

14-3-3 Epsilon Dynamically Interacts with Key Components of Mitogen-Activated Protein Kinase Signal Module for Selective Modulation of the Tnf-Alpha-Induced Time Course-Dependent Nf-Kappa B Activity

IkappaBbeta acts to inhibit and activate gene expression during the inflammatory response.

Role Of Protein Kinase C Beta(2) Activation In Tnf-Alpha-Induced Human Vascular Endothelial Cell Apoptosis

Etk/Bmx Transactivates Vascular Endothelial Growth Factor 2 and Recruits Phosphatidylinositol 3-Kinase to Mediate the Tumor Necrosis Factor-Induced Angiogenic Pathway.

LXR Agonist T0901317 Upregulates Thrombomodulin Expression in Glomerular Endothelial Cells by Inhibition of Nuclear Factor‑κb.

Orphan Nuclear Receptors Nur77 and Nor1 Are Novel Regulators of Thrombotic Function in Vascular Endothelial Cells

Selective regulation of tumor necrosis factor–induced Erk signaling by Src family kinases and the T cell protein tyrosine phosphatase

Thrombomodulin is essential for maintaining quiescence in vascular endothelial cells

Downregulation of BDNF Expression by PKC and by TNF-α in Human Endothelial Cells

Thrombomodulin modulates growth of tumor cells independent of its anticoagulant activity.

Proteasome Inhibitors Enhance Endothelial Thrombomodulin Expression Via Induction of Krüppel-Like Transcription Factors

MK2 Posttranscriptionally Regulates TNF-α-induced Expression of ICAM-1 and IL-8 Via Tristetraprolin in Human Pulmonary Microvascular Endothelial Cells.

Klf2 Suppresses Tgf-Beta Signaling in Endothelium Through Induction of Smad7 and Inhibition of Ap-1

Liver Kinase B1 is Required for Thromboxane Receptor-Dependent Nuclear Factor-Κb Activation and Inflammatory Responses.

Opposite regulation by PI3K/Akt and MAPK/ERK pathways of tissue factor expression, cell-associated procoagulant activity and invasiveness in MDA-MB-231 cells